Biodesix, Inc. Common Stock
Symbol: BDSX (NASDAQ)
Company Description:
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
- Today's Open: $7.75
- Today's High: $8.03
- Today's Low: $7.725
- Today's Volume: 20.96K
- Yesterday Close: $7.75
- Yesterday High: $8.42
- Yesterday Low: $7.58
- Yesterday Volume: 54.15K
- Last Min Volume: 1
- Last Min High: $7.8
- Last Min Low: $7.8
- Last Min VWAP: $7.8
- Name: Biodesix, Inc. Common Stock
- Website: https://www.biodesix.com
- Listed Date: 2020-10-28
- Location: LOUISVILLE, CO
- Market Status: Active
- CIK Number: 0001439725
- SIC Code: 8071
- SIC description: SERVICES-MEDICAL LABORATORIES
- Market Cap: $62.00M
- Round Lot: 100
- Outstanding Shares: 8.00M
- Asset Type: CS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-23 | SCHEDULE 13D/A | View |
| 2025-09-23 | 4 | View |
| 2025-09-19 | 4 | View |
| 2025-09-15 | 8-K | View |
| 2025-09-11 | 8-K | View |
| 2025-09-03 | SCHEDULE 13D/A | View |
| 2025-09-03 | 4 | View |
| 2025-08-14 | 4 | View |
| 2025-08-14 | 4 | View |
| 2025-08-14 | 4 | View |
| 2025-08-14 | 4 | View |
| 2025-08-14 | 4 | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-02 | 4 | View |
| 2025-07-02 | 4 | View |
| 2025-05-30 | S-8 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |
| 2025-05-22 | 4 | View |